Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | F7 | P08709 | 3/20 | 0.55 |
| ▸ | F3 | P13726 | 3/20 | 0.55 |
| ▸ | PPARG | P37231 | 3/20 | 0.55 |
| ▸ | PPARD | Q03181 | 2/20 | 0.55 |
| ▸ | PPARA | Q07869 | 2/20 | 0.55 |
| ▸ | FABP3 | P05413 | 2/20 | 0.55 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | FABP4 | P15090 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29284430 | 1.00 | TRPV1 (0.57) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL21409559 | 1.00 | TRPV1 (0.57) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL28637577 | 1.00 | TRPV1 (0.57) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL7289670 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL25181797 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL25182431 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL7289665 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL21694666 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL25178025 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 | |
| SCHEMBL21694668 | 0.98 | FAAH (0.54) | TRPV1ALDH1A1KDM4EF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11901249-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| US-11873356-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11548977-B2 | Active ester resin and composition and cured product using the same | DIC CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| US-11407708-B2 | Active ester compound and composition and cured product obtained using the same | DIC CORPORATION (JP) | 2022-08-09 | — | — | US | disclosed |
| US-20210032383-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2021-02-04 | — | — | US | disclosed |
| US-20210009804-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2021-01-14 | — | — | US | disclosed |
| CN-112119104-A | Epoxy (meth) acrylate resin composition, curable resin composition, cured product, and article | DIC株式会社 | 2020-12-22 | — | — | CN | disclosed |
| CN-112105661-A | Acid group-containing (meth) acrylate resin composition, curable resin composition, cured product, insulating material, resin material for solder resist, and protective member | DIC株式会社 | 2020-12-18 | — | — | CN | disclosed |
| CN-111971323-A | Curable composition and cured product thereof | DIC株式会社 | 2020-11-20 | — | — | CN | disclosed |
| US-20200216603-A1 | ACTIVE ESTER RESIN AND COMPOSITION AND CURED PRODUCT USING THE SAME | DIC CORPORATION (JP) | 2020-07-09 | — | — | US | disclosed |
| US-20200207700-A1 | ACTIVE ESTER COMPOUND AND COMPOSITION AND CURED PRODUCT OBTAINED USING THE SAME | DIC CORPORATION (JP) | 2020-07-02 | — | — | US | disclosed |
| WO-2019188332-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019188330-A1 | CURABLE COMPOSITION AND CURED PRODUCT OF SAME | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019188333-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207700-A1 | ACTIVE ESTER COMPOUND AND COMPOSITION AND CURED PRODUCT OBTAINED USING THE SAME | CRAT, CYP19A1, EP300 | TRPV1 248/4885ALDH1A1 19/4885KDM4E 479/4885 |
| US-11407708-B2 | Active ester compound and composition and cured product obtained using the same | CRAT, CYP19A1, EP300 | TRPV1 248/4885ALDH1A1 19/4885KDM4E 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.